SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000898430-99-000950
Filing Date
1999-03-16
Accepted
1999-03-16 00:00:00
Documents
9
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 262108
2 AMENDED & RESTATED 1991 EQUITY INCENTIVE PLAN EX-10.1 49535
3 AMGEN RETIREMENT & SAVINGS PLAN EX-10.2 3650
4 CHANGE OF CONTROL SEVERANCE PLAN EX-10.28 45418
5 SUBSIDIARIES OF THE COMPANY EX-21 3378
6 FINANCIAL DATA SCHEDULE EX-27 2704
7 AMENDED & RESTATED FINANCIAL DATA SCHEDULE EX-27.1 3865
8 AMENDED & RESTATED FINANCIAL DATA SCHEDULE EX-27.2 4767
9 AMENDED & RESTATED FINANCIAL DATA SCHEDULE EX-27.3 4765
  Complete submission text file 0000898430-99-000950.txt   382630
Mailing Address 1840 DEHAVILLAND DR. MAIL STOP 10-1-B-512 THOUSAND OAKS CA 91320-1789
Business Address 1840 DEHAVILLAND DR THOUSAND OAKS CA 91320-1789 0854471000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12477 | Film No.: 99566411
SIC: 2836 Biological Products, (No Diagnostic Substances)